Strongyloides seroprevalence before and after an ivermectin mass drug administration in a remote Australian Aboriginal community.

• Ngā kaituhi matua: Therese M Kearns (Author), Bart J Currie (Author), Allen C Cheng (Author), James McCarthy (Author), Jonathan R Carapetis (Author), Deborah C Holt (Author), Wendy Page (Author), Jennifer Shield (Author), Roslyn Gundjirryirr (Author), Eddie Mulholland (Author), Linda Ward (Author), Ross M Andrews (Author)
• Hōputu: Pukapuka
• I whakaputaina: Public Library of Science (PLoS), 2017-05-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

BACKGROUND:Strongyloides seroprevalence is hyper-endemic in many Australian Aboriginal and Torres Strait Islander communities, ranging from 35-60%. We report the impact on Strongyloides seroprevalence after two oral ivermectin mass drug administrations (MDAs) delivered 12 months apart in a remote Au...